These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30658688)

  • 1. ERG oncoprotein expression in prostatic acinar adenocarcinoma; clinicopathologic significance.
    Hashmi AA; Khan EY; Irfan M; Ali R; Asif H; Naeem M; Nisar L; Faridi N; Khan A; Edhi MM
    BMC Res Notes; 2019 Jan; 12(1):35. PubMed ID: 30658688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of High Androgen Receptor Expression in Prostatic Acinar Adenocarcinoma.
    Hashmi AA; Mudassir G; Irfan M; Hussain ZF; Hashmi SK; Asif H; Nisar L; Naeem M; Faridi N
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):893-896. PubMed ID: 30912411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic role of ERG immunopositivity in prostatic acinar adenocarcinoma: a study including 454 cases and review of the literature.
    Xu B; Chevarie-Davis M; Chevalier S; Scarlata E; Zeizafoun N; Dragomir A; Tanguay S; Kassouf W; Aprikian A; Brimo F
    Hum Pathol; 2014 Mar; 45(3):488-97. PubMed ID: 24406017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
    Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
    Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas.
    Morais CL; Herawi M; Toubaji A; Albadine R; Hicks J; Netto GJ; De Marzo AM; Epstein JI; Lotan TL
    Prostate; 2015 Oct; 75(14):1610-9. PubMed ID: 26178158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression.
    Warrick JI; Humphrey PA
    Am J Surg Pathol; 2013 Nov; 37(11):1709-14. PubMed ID: 23797726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ERG and PTEN protein expression in cribriform architecture prostate carcinomas.
    Downes MR; Satturwar S; Trudel D; van der Kwast TH
    Pathol Res Pract; 2017 Jan; 213(1):34-38. PubMed ID: 27913052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of estimation of ERG expression in prostate adenocarcinoma and high-grade prostatic intraepithelial neoplasia].
    Allina DO; Kekeeva TV; Moskvina LV; Shikeeva AA; Andreeva YY; Zavalishina LE; Frank GA
    Arkh Patol; 2015; 77(5):36-42. PubMed ID: 26978019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Significance of ERG and Androgen Receptor Expression in Adenocarcinoma Prostate.
    Husain I; Sagar P; Shukla S; Babu S; Singhai A; Sankhwar SN; Husain N
    Kathmandu Univ Med J (KUMJ); 2018 Oct.-Dec.; 16(64):277-280. PubMed ID: 31729338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer.
    Box A; Alshalalfa M; Hegazy SA; Donnelly B; Bismar TA
    Tumour Biol; 2016 Sep; 37(9):12287-12299. PubMed ID: 27271990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropilin-2 is an independent prognostic factor for shorter cancer-specific survival in patients with acinar adenocarcinoma of the prostate.
    Borkowetz A; Froehner M; Rauner M; Conrad S; Erdmann K; Mayr T; Datta K; Hofbauer LC; Baretton GB; Wirth M; Fuessel S; Toma M; Muders MH
    Int J Cancer; 2020 May; 146(9):2619-2627. PubMed ID: 31509606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of ERG oncoprotein is associated with a less aggressive tumor phenotype in Japanese prostate cancer patients.
    Kimura T; Furusato B; Miki J; Yamamoto T; Hayashi N; Takahashi H; Kamata Y; van Leenders GJ; Visakorpi T; Egawa S
    Pathol Int; 2012 Nov; 62(11):742-8. PubMed ID: 23121605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlap of CD44 expression between prostatic small cell carcinoma and acinar adenocarcinoma.
    Wang CC; De Marzo AM; Lotan TL; Epstein JI
    Hum Pathol; 2015 Apr; 46(4):554-7. PubMed ID: 25656929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPINK1 expression in relation to PTEN and ERG in matched primary and lymph node metastatic prostate cancer: Implications for biomarker development.
    Huang KC; Bégin LR; Palanisamy N; Donnelly B; Bismar TA
    Urol Oncol; 2016 May; 34(5):235.e1-10. PubMed ID: 26725250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants of acinar adenocarcinoma of the prostate mimicking benign conditions.
    Humphrey PA
    Mod Pathol; 2018 Jan; 31(S1):S64-70. PubMed ID: 29297496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer.
    Kim SH; Kim SH; Joung JY; Lee GK; Hong EK; Kang KM; Yu A; Nam BH; Chung J; Seo HK; Park WS; Lee KH
    PLoS One; 2015; 10(4):e0122498. PubMed ID: 25897494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micropapillary carcinoma: new variant of prostatic acinar adenocarcinoma.
    Mneimneh WS; Linos K; Shah P; Jennings TA; Fisher H; Nazeer T
    Arch Pathol Lab Med; 2012 Nov; 136(11):1447-50. PubMed ID: 23106591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERG positive prostatic cancer may show a more angiogenetic phenotype.
    Strzępek A; Kaczmarczyk K; Białas M; Szpor J; Dyduch G; Szopiński T; Chłosta P; Okoń K
    Pathol Res Pract; 2014 Dec; 210(12):897-900. PubMed ID: 25220615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
    He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
    BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.